Rula Al-Shahrabi
Overview
Explore the profile of Rula Al-Shahrabi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saheb Sharif-Askari F, Al-Shahrabi R, Al Shareef Z
Prostate
. 2024 Aug;
84(15):1415.
PMID: 39166801
No abstract available.
2.
Al Shareef Z, Al-Shahrabi R, Saheb Sharif-Askari F, AlDhmanie A, Alshamsi Y, Zarooni A, et al.
Prostate
. 2023 Nov;
84(2):185-192.
PMID: 37969038
Background: Prostate cancer (PCa) is a prevalent disease worldwide. However, the incidence and patient-specific risk factors of PCa in the Middle East, specifically in the United Arab Emirates, have not...
3.
Al Shareef Z, Al-Shahrabi R, Saheb Sharif-Askari F, Alshamsi Y, Zarooni A, Alkhayyal N, et al.
Front Oncol
. 2023 Jun;
13:1180902.
PMID: 37287914
Background: Prostatic hyperplasia (BPH) and prostate cancer (PCa) are common age-related diseases in men. According to World Health Organization (WHO), PCa is the second most common cancer among Emirati men....
4.
Evaluation of nanoparticles with 5-fluorouracil and chloroquine on Acanthamoeba castellanii activity
Saeed B, Qalaji M, Akbar N, Siddiqui R, Roberta C, Manzoor S, et al.
Mol Biochem Parasitol
. 2022 Jun;
250:111492.
PMID: 35714753
Acanthamoeba is opportunistic pathogens that cause vision-threatening Acanthamoeba keratitis (AK). Previous studies proposed the use of chloroquine (CQ) and 5-fluorouracil (5FU) as anti-Acanthamoeba agents. The objective of this study was...
5.
Saeed B, Al-Shahrabi R, Alhaj S, Alkokhardi Z, Adrees A
Int J Infect Dis
. 2021 Aug;
111:219-226.
PMID: 34384899
Objectives: Vaccines are one of the best interventions developed for eradicating COVID-19. This study aimed to provide evidence on Sinopharm COVID-19 vaccine side effects. Methods: A cross-sectional survey study was...
6.
Saeed B, Al-Shahrabi R, Bolarinwa O
PLoS One
. 2021 Mar;
16(3):e0249310.
PMID: 33788835
Since the World Health Organization (WHO) announced that the coronavirus disease (COVID-19) is a worldwide pandemic, many countries' authorities, including the Iraqi authorities, started responding and taking action to control...